OTSUKA PHARMACEUTICAL NETHERLANDS BV

Italy

All drugs from this manufacturer

  • ABILIFY

    It is used for the treatment of adults and adolescents (from 15 years of age and older) suffering from conditions characterized by symptoms such as perceiving things that are not present, suspiciousness, inconsistent behavior, or emotional flattening. It is also used for adults and adolescents (from 13 years of age and older) with symptoms of excessive energy, reduced need for sleep, and irritability, and to prevent their recurrence in adults.

    Dosage form: tablets

    Active substance Dosage
    aripiprazole -

    ATC: N05AX12

  • ABILIFY MAINTENA

    It is used for the treatment of schizophrenia in adults who have already been stabilized with oral aripiprazole treatment.

    Dosage form: powder and solvent for preparation of suspension for injection, prolonged release

    Active substance Dosage
    aripiprazole -

    ATC: N05AX12

  • INAQOVI

    It is used for the treatment of acute myeloid leukemia (AML) in adults, when chemotherapy is not considered a suitable therapeutic option.

    Dosage form: tablets, film-coated

    Active substance Dosage
    decitabine -
    cedazuridine -

    ATC: L01BC58

  • JINARC

    It is used to treat a condition called 'autosomal dominant polycystic kidney disease' (ADPKD) in adults with stage 1 to 4 chronic kidney disease who show rapid disease progression. The drug helps slow the development of cysts in the kidneys, reduces symptoms, and increases urine production.

    Dosage form: tablets

    Active substance Dosage
    tolvaptan -

    ATC: C03XA01

  • LUPKYNIS

    It is used for the treatment of adults (18 years and older) suffering from lupus nephritis, which is kidney inflammation caused by lupus. The drug helps to reduce kidney inflammation, alleviates symptoms such as swelling, high blood pressure, and fatigue, and improves kidney function.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    voclosporin -

    ATC: L04AD03

  • RXULTI

    It is used to treat schizophrenia in adults and adolescents aged 13 years and older. It helps control symptoms (such as hallucinations, suspicion, or senseless behavior) and prevent relapses.

    Dosage form: tablets, film-coated

    Active substance Dosage
    brexpiprazolo -

    ATC: N05AX16

  • SAMSCA

    It is used to treat patients with low sodium concentrations in the blood caused by syndrome of inappropriate antidiuretic hormone secretion (SIADH), a condition in which the kidneys retain too much water.

    Dosage form: tablets

    Active substance Dosage
    tolvaptan -

    ATC: C03XA01